The Latest Cardiac and Vascular News
Study shows 97.3% accuracy in identifying arrhythmia source locations in nine atrial and ventricular arrhythmias and pacing types across all four heart chambers. September 07, 2022 08:34 AM Eastern Daylight Time SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, the developer of the world’s first technology to rapidly map cardiac arrhythmias using only 12-lead […]
Physicians in Europe now have access to Penumbra’s latest stroke technology for mechanical thrombectomy RED® reperfusion catheters are designed with optimized trackability and aspiration efficiency to help navigate the complex anatomy of the brain and deliver powerful aspiration for the removal of blood clots Initial INSIGHT Registry data presented at WFITN […]
Survey of cardiac rehab clinicians finds that over half started using RPM within just the last two years Campbell, Calif. – September 7, 2022 – Vivalink, a leading provider of digital healthcare solutions, today announces the results of its survey of cardiac rehabilitation clinicians and their insights into the current […]
WATCHMAN FLX now the only LAAC technology in the United States that allows for either DAPT or OAC immediately following implantation MARLBOROUGH, Mass., Sept. 6, 2022 /PRNewswire/ — Boston Scientific Corporation ( NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use labeling for the current-generation WATCHMAN FLX™ Left […]
SCHAFFHAUSEN, SWITZERLAND / ACCESSWIRE / September 6, 2022 / Occlutech Holding AG Occlutech Holding AG (“Occlutech”), one of the world’s leading providers of minimally invasive structural heart disease devices has expanded its Executive Management Team by appointing two new members. Jose de la Cortina has been recruited as Chief Commercial Officer […]
This follow-up trial builds on AtriAN’s initial safety and feasibility study and aims to assess the efficacy of its cardioneuroablation treatment in patients with atrial fibrillation. GALWAY, Ireland, Sept. 6, 2022 /PRNewswire/ — AtriAN Medical today announced that it has completed enrollment of a second study using its selective pulsed field ablation (PFA) […]
The OCTARAY™ Mapping Catheter with TRUEref™ Technology provides physicians with the precise information needed for catheter ablation procedures that treat cardiac arrhythmias1,2† IRVINE, Calif., Sept. 6, 2022 /PRNewswire/ — Biosense Webster, Inc., part of Johnson & Johnson MedTech‡, today announced the release of the OCTARAY™ Mapping Catheter with TRUEref™ Technology powered by the […]
SHENZHEN, China, Sept. 5, 2022 /PRNewswire/ — LifeTech Scientific Corporation (Stock Code: 1302.HK) is pleased to announce that on 30 August 2022, an FDA-approved investigator-initiated pre-market clinical trial of its proprietary LAmbre™ Plus Left Atrial Appendage (LAA) Closure System has obtained medical insurance coverage in the United States, meaning that all patient enrollment of […]
SOUTH SAN FRANCISCO, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, announced clearance of its Investigational New Drug (IND) application to begin clinical testing of […]
NEW YORK, Sept. 1, 2022 /PRNewswire/ — Sunil V. Rao, MD, one of the world’s premier clinician-investigators in the field of interventional cardiology, has been named director of interventional cardiology at NYU Langone Health and the director of the cardiac catheterization laboratory at the Manhattan campus of NYU Langone. Dr. Rao, who will also […]
